LASIK microkeratomes, a cost-effective solution

Article

At this year's ESCRS in Paris, Moria showcased its One range of single-use, high precision, handheld surgical instruments, including the One Use-Plus SBK.

At this year's ESCRS in Paris, Moria showcased its One range of single-use, high precision, handheld surgical instruments, including the One Use-Plus SBK. This new generation of LASIK microkeratomes reportedly achieves accuracy and visual results equivalent to femtolasers at a fraction of the cost.

The One Use-Plus system is a linear, automated, microkeratome featuring a nasal hinge and two head sizes (90 and 130) for customizable flap thickness of 100 µm and 130 µm on average, respectively. In addition to this surgeons can benefit from three single use suction rings, -1, 0 and +1, to accommodate for all keratometries. The company claims the instrument can help doctors achieve predictable, thin flaps with planar profiles, resulting in outstanding visual outcomes that are equivalent or better than those achieved with a femtolaser with less discomfort to the patient.

Moria has been working with corneal surgeons in the field of DSAEK on the relatively new technique of Ultra-Thin DSAEK.

For more information on the One range of products visit the company's website at www.moria-surgical.com

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.